Design and Biological Evaluation of Cdc20 Inhibitors via Fragment Merging: A Computationally Proposed Adjacent Lateral Sub-Pocket Hypothesis
Authors:
- Qiwan WenQWQiwan Wen
- Qingsong ChenQCQingsong Chen
- Shuyang CaoSCShuyang Cao
- Xiangyang LeXLXiangyang Le
- Lei ZhangLZLei Zhang
- Xiaoqi WengXWXiaoqi Weng
- Junjie WeiJWJunjie Wei
- Shuang SunSSShuang Sun
- Yang BaiYBYang Bai
- Qianbin LiQLQianbin Li
- Zhuo ChenZCZhuo Chen
- 20 November 2026
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
This publication has 28 references indexed in Scilit:
- Comparative analysis of molecular 3D metrics in fragment space and beyondDrug Discovery Today, 2025
- Design, synthesis and optimization of Apcin analogues as Cdc20 inhibitors for triple-negative breast cancer therapyEuropean Journal of Medicinal Chemistry, 2025
- Securin acetylation prevents precocious separase activation and premature sister chromatid separationCurrent Biology, 2024
- Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancerEuropean Journal of Medicinal Chemistry, 2024
- DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutationsProtein Science, 2020
- A novel strategy to block mitotic progression for targeted therapyEBioMedicine, 2019
- Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cellsEBioMedicine, 2019
- APCCdc20 Suppresses Apoptosis through Targeting Bim for Ubiquitination and DestructionDevelopmental Cell, 2014
- Multiwfn: A multifunctional wavefunction analyzerJournal of Computational Chemistry, 2011
- Cdc20: A WD40 Activator for a Cell Cycle Degradation MachineMolecular Cell, 2007